I acknowledge Dr Reti's contributions as part of that process around the submissions that were received by the select committee. Five of the six submissions that were received were in support. The outstanding one was that of Pfizer, who didn't explicitly comment in favour or against the bill. The committee, in its report, notes that that's appropriate given the commercial relationship that Pfizer has with the Government. We also heard from the Minister for COVID-19 Response and was reassured with the responses that he was able to provide to the select committee. 